{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:02:17Z","timestamp":1779757337049,"version":"3.53.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["DFL20221402"],"award-info":[{"award-number":["DFL20221402"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09947-7","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:36:49Z","timestamp":1774967809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Questiomycin A demonstrates antibacterial activity against Mycobacterium tuberculosis by directly targeting FabD"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0319-216X","authenticated-orcid":false,"given":"Lingling","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinda","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chennan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxue","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-1884","authenticated-orcid":false,"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"9947_CR1","unstructured":"World Health Organization. Global Tuberculosis Report 2024. (World Health Organization, 2024)."},{"key":"9947_CR2","doi-asserted-by":"publisher","first-page":"2344821","DOI":"10.1080\/07853890.2024.2344821","volume":"56","author":"P Gu","year":"2024","unstructured":"Gu, P. et al. Effectiveness, cost, and safety of four regimens recommended by WHO for RR\/MDR-TB treatment: a cohort study in Eastern China. Ann. Med. 56, 2344821 (2024).","journal-title":"Ann. Med."},{"key":"9947_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1021\/acs.jafc.2c06373","volume":"71","author":"FJR Mej\u00edas","year":"2023","unstructured":"Mej\u00edas, F. J. R. et al. Stability and pK(a) modulation of aminophenoxazinones and their disulfide mimics by host-guest interaction with Cucurbit[7]uril. Direct applications in agrochemical wheat models. J. Agric. Food Chem. 71, 480\u2013487 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"9947_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1248\/bpb.33.188","volume":"33","author":"T Hanawa","year":"2010","unstructured":"Hanawa, T. et al. In vitro antibacterial activity of Phx-3 against Helicobacter pylori. Biol. Pharm. Bull. 33, 188\u2013191 (2010).","journal-title":"Biol. Pharm. Bull."},{"key":"9947_CR5","doi-asserted-by":"publisher","first-page":"8566","DOI":"10.1039\/D1GC02908H","volume":"23","author":"J Zhou","year":"2021","unstructured":"Zhou, J., Ma, Z.-Y., Shonhe, C., Ji, S.-H. & Cai, Y.-R. TEMPO-catalyzed electrochemical dehydrogenative cyclocondensation of o-aminophenols: synthesis of aminophenoxazinones as antiproliferative agents. Green. Chem. 23, 8566\u20138570 (2021).","journal-title":"Green. Chem."},{"key":"9947_CR6","first-page":"341","volume":"25","author":"H Nagata","year":"2011","unstructured":"Nagata, H. et al. Rapid decrease of intracellular pH associated with inhibition of Na+\/H+ exchanger precedes apoptotic events in the MNK45 and MNK74 gastric cancer cell lines treated with 2-aminophenoxazine-3-one. Oncol. Rep. 25, 341\u2013346 (2011).","journal-title":"Oncol. Rep."},{"key":"9947_CR7","doi-asserted-by":"publisher","first-page":"929161","DOI":"10.3389\/fphar.2022.929161","volume":"13","author":"Y Bahrami","year":"2022","unstructured":"Bahrami, Y., Bouk, S., Kakaei, E. & Taheri, M. Natural products from Actinobacteria as a potential source of new therapies against colorectal cancer: a review. Front. Pharmacol. 13, 929161 (2022).","journal-title":"Front. Pharmacol."},{"key":"9947_CR8","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.3390\/molecules27207099","volume":"27","author":"K Yong","year":"2022","unstructured":"Yong, K., Kaleem, S., Ma, M., Lian, X. & Zhang, Z. Antiglioma natural products from the marine-associated fungus Penicillium sp. ZZ1750. Molecules 27, 7099 (2022).","journal-title":"Molecules"},{"key":"9947_CR9","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1021\/acs.jafc.2c03216","volume":"70","author":"S Guo","year":"2022","unstructured":"Guo, S., Hu, H., Wang, W., Bilal, M. & Zhang, X. Production of antibacterial questiomycin A in metabolically engineered Pseudomonas chlororaphis HT66. J. Agric. Food Chem. 70, 7742\u20137750 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"9947_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ja.2006.12","volume":"59","author":"J Bitzer","year":"2006","unstructured":"Bitzer, J. et al. New aminophenoxazinones from a marine Halomonas sp.: fermentation, structure elucidation, and biological activity. J. Antibiot. 59, 86\u201392 (2006).","journal-title":"J. Antibiot."},{"key":"9947_CR11","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.3390\/molecules26113453","volume":"26","author":"JG Zorrilla","year":"2021","unstructured":"Zorrilla, J. G. et al. Pharmacological activities of aminophenoxazinones. Molecules 26, 3453 (2021).","journal-title":"Molecules"},{"key":"9947_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.tube.2009.05.008","volume":"89","author":"S Ananthan","year":"2009","unstructured":"Ananthan, S. et al. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis 89, 334\u2013353 (2009).","journal-title":"Tuberculosis"},{"key":"9947_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.chemosphere.2003.09.044","volume":"54","author":"IS Fomsgaard","year":"2004","unstructured":"Fomsgaard, I. S., Mortensen, A. G. & Carlsen, S. C. Microbial transformation products of benzoxazolinone and benzoxazinone allelochemicals-a review. Chemosphere 54, 1025\u20131038 (2004).","journal-title":"Chemosphere"},{"key":"9947_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1620\/tjem.203.47","volume":"203","author":"S Shimizu","year":"2004","unstructured":"Shimizu, S. et al. Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J. Exp. Med. 203, 47\u201352 (2004).","journal-title":"Tohoku J. Exp. Med."},{"key":"9947_CR15","doi-asserted-by":"publisher","first-page":"891610","DOI":"10.3389\/fmicb.2022.891610","volume":"13","author":"FSM Hopf","year":"2022","unstructured":"Hopf, F. S. M. et al. Bacterial enoyl-reductases: the ever-growing list of fabs, their mechanisms and inhibition. Front. Microbiol. 13, 891610 (2022).","journal-title":"Front. Microbiol."},{"key":"9947_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.febslet.2010.02.038","volume":"584","author":"SK Hong","year":"2010","unstructured":"Hong, S. K. et al. New design platform for malonyl-CoA-acyl carrier protein transacylase. FEBS Lett. 584, 1240\u20131244 (2010).","journal-title":"FEBS Lett."},{"key":"9947_CR17","doi-asserted-by":"publisher","first-page":"12961","DOI":"10.1074\/jbc.270.22.12961","volume":"270","author":"L Serre","year":"1995","unstructured":"Serre, L., Verbree, E. C., Dauter, Z., Stuitje, A. R. & Derewenda, Z. S. The Escherichia coli malonyl-CoA:acyl carrier protein transacylase at 1.5-A resolution. Crystal structure of a fatty acid synthase component. J. Biol. Chem. 270, 12961\u201312964 (1995).","journal-title":"J. Biol. Chem."},{"key":"9947_CR18","doi-asserted-by":"publisher","first-page":"24224","DOI":"10.1073\/pnas.2009805117","volume":"117","author":"LE Misson","year":"2020","unstructured":"Misson, L. E. et al. Interfacial plasticity facilitates high reaction rate of E. coli FAS malonyl-CoA:ACP transacylase, FabD. Proc. Natl. Acad. Sci. USA 117, 24224\u201324233 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9947_CR19","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1128\/JB.181.17.5498-5504.1999","volume":"181","author":"AJ Kutchma","year":"1999","unstructured":"Kutchma, A. J., Hoang, T. T. & Schweizer, H. P. Characterization of a Pseudomonas aeruginosa fatty acid biosynthetic gene cluster: purification of acyl carrier protein (ACP) and malonyl-coenzyme A:ACP transacylase (FabD). J. Bacteriol. 181, 5498\u20135504 (1999).","journal-title":"J. Bacteriol."},{"key":"9947_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jmb.2007.06.004","volume":"371","author":"Z Li","year":"2007","unstructured":"Li, Z. et al. The crystal structure of MCAT from Mycobacterium tuberculosis reveals three new catalytic models. J. Mol. Biol. 371, 1075\u20131083 (2007).","journal-title":"J. Mol. Biol."},{"key":"9947_CR21","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","volume":"41","author":"L Collins","year":"1997","unstructured":"Collins, L. & Franzblau, S. G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41, 1004\u20131009 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9947_CR22","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1128\/JCM.37.6.1881-1884.1999","volume":"37","author":"DM Hacek","year":"1999","unstructured":"Hacek, D. M., Dressel, D. C. & Peterson, L. R. Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique. J. Clin. Microbiol. 37, 1881\u20131884 (1999).","journal-title":"J. Clin. Microbiol."},{"key":"9947_CR23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00974-21","volume":"65","author":"S Guo","year":"2021","unstructured":"Guo, S. et al. In vitro and in vivo activity of oxazolidinone candidate OTB-658 against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 65, e0097421 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9947_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1128\/AAC.48.1.340-343.2004","volume":"48","author":"CY Chan","year":"2004","unstructured":"Chan, C. Y., Au-Yeang, C., Yew, W. W., Leung, C. C. & Cheng, A. F. In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48, 340\u2013343 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9947_CR25","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1128\/AAC.45.12.3631-3634.2001","volume":"45","author":"CY Chan","year":"2001","unstructured":"Chan, C. Y., Au-Yeang, C., Yew, W. W., Hui, M. & Cheng, A. F. Postantibiotic effects of antituberculosis agents alone and in combination. Antimicrob. Agents Chemother. 45, 3631\u20133634 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9947_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/jac\/dkm485","volume":"61","author":"PC Karakousis","year":"2007","unstructured":"Karakousis, P. C., Williams, E. P. & Bishai, W. R. Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 61, 323\u2013331 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"9947_CR27","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.1074\/jbc.M117.797563","volume":"292","author":"MZ Khan","year":"2017","unstructured":"Khan, M. Z. et al. Protein kinase G confers survival advantage to Mycobacterium tuberculosis during latency-like conditions. J. Biol. Chem. 292, 16093\u201316108 (2017).","journal-title":"J. Biol. Chem."},{"key":"9947_CR28","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.7150\/thno.45951","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Melatonin overcomes MCR-mediated colistin resistance in Gram-negative pathogens. Theranostics 10, 10697\u201310711 (2020).","journal-title":"Theranostics"},{"key":"9947_CR29","doi-asserted-by":"publisher","first-page":"e1009909","DOI":"10.1371\/journal.ppat.1009909","volume":"17","author":"Y Xia","year":"2021","unstructured":"Xia, Y. et al. Elucidating the mechanism by which synthetic helper peptides sensitize Pseudomonas aeruginosa to multiple antibiotics. PLoS Pathog. 17, e1009909 (2021).","journal-title":"PLoS Pathog."},{"key":"9947_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/mmi.14220","volume":"111","author":"M Hohl","year":"2019","unstructured":"Hohl, M. et al. Increased drug permeability of a stiffened mycobacterial outer membrane in cells lacking MFS transporter Rv1410 and lipoprotein LprG. Mol. Microbiol. 111, 1263\u20131282 (2019).","journal-title":"Mol. Microbiol."},{"key":"9947_CR31","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188242","volume":"14","author":"A Mateus","year":"2018","unstructured":"Mateus, A. et al. Thermal proteome profiling in bacteria: probing protein state in vivo. Mol. Syst. Biol. 14, e8242 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"9947_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255784","volume":"346","author":"MM Savitski","year":"2014","unstructured":"Savitski, M. M. et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science 346, 1255784 (2014).","journal-title":"Science"},{"key":"9947_CR33","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/emmm.201201689","volume":"4","author":"RC Hartkoorn","year":"2012","unstructured":"Hartkoorn, R. C. et al. Towards a new tuberculosis drug: pyridomycin - nature\u2019s isoniazid. EMBO Mol. Med. 4, 1032\u20131042 (2012).","journal-title":"EMBO Mol. Med."},{"key":"9947_CR34","doi-asserted-by":"publisher","first-page":"27967","DOI":"10.1074\/jbc.M103687200","volume":"276","author":"L Kremer","year":"2001","unstructured":"Kremer, L. et al. Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J. Biol. Chem. 276, 27967\u201327974 (2001).","journal-title":"J. Biol. Chem."},{"key":"9947_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0003-2697(03)00327-0","volume":"319","author":"J Molnos","year":"2003","unstructured":"Molnos, J., Gardiner, R., Dale, G. E. & Lange, R. A continuous coupled enzyme assay for bacterial malonyl-CoA:acyl carrier protein transacylase (FabD). Anal. Biochem. 319, 171\u2013176 (2003).","journal-title":"Anal. Biochem."},{"key":"9947_CR36","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1002\/cbic.202100333","volume":"22","author":"GV Janssen","year":"2021","unstructured":"Janssen, G. V. et al. Development of Tyrphostin Analogues to Study Inhibition of the Mycobacterium tuberculosis Pup Proteasome System*. ChemBioChem 22, 3082\u20133089 (2021).","journal-title":"ChemBioChem"},{"key":"9947_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","volume":"18","author":"K Takayama","year":"2005","unstructured":"Takayama, K., Wang, C. & Besra, G. S. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18, 81\u2013101 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"9947_CR38","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1126\/science.1163885","volume":"322","author":"MJ Pearce","year":"2008","unstructured":"Pearce, M. J., Mintseris, J., Ferreyra, J., Gygi, S. P. & Darwin, K. H. Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science 322, 1104\u20131107 (2008).","journal-title":"Science"},{"key":"9947_CR39","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jmb.2005.09.016","volume":"353","author":"R Veyron-Churlet","year":"2005","unstructured":"Veyron-Churlet, R. et al. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions. J. Mol. Biol. 353, 847\u2013858 (2005).","journal-title":"J. Mol. Biol."},{"key":"9947_CR40","doi-asserted-by":"publisher","first-page":"125022","DOI":"10.1016\/j.ijbiomac.2023.125022","volume":"243","author":"S Sreelatha","year":"2023","unstructured":"Sreelatha, S., Nagarajan, U. & Natarajan, S. Protein targets in Mycobacterium tuberculosis and their inhibitors for therapeutic implications: a narrative review. Int. J. Biol. Macromol. 243, 125022 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"9947_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3109\/10409238.2014.925420","volume":"49","author":"SK Angala","year":"2014","unstructured":"Angala, S. K., Belardinelli, J. M., Huc-Claustre, E., Wheat, W. H. & Jackson, M. The cell envelope glycoconjugates of Mycobacterium tuberculosis. Crit. Rev. Biochem. Mol. Biol. 49, 361\u2013399 (2014).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"9947_CR42","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.2174\/1381612819666131118203641","volume":"20","author":"EJ North","year":"2014","unstructured":"North, E. J., Jackson, M. & Lee, R. E. New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics. Curr. Pharm. Des. 20, 4357\u20134378 (2014).","journal-title":"Curr. Pharm. Des."},{"key":"9947_CR43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa, A. N., Subbian, S., Hanna, L. E. & Selvakumar, N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect. Genet. Evol. 45, 474\u2013492 (2016).","journal-title":"Infect. Genet. Evol."},{"key":"9947_CR44","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1080\/07391102.2023.2233622","volume":"42","author":"S Sundararajan","year":"2024","unstructured":"Sundararajan, S., Karunakaran, K. & Muniyan, R. Structure-based virtual screening and discovery of novel inhibitors against FabD protein of Mycobacterium tuberculosis. J. Biomol. Struct. Dyn. 42, 6280\u20136291 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"9947_CR45","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.bbalip.2016.09.014","volume":"1862","author":"J Yao","year":"2017","unstructured":"Yao, J. & Rock, C. O. Bacterial fatty acid metabolism in modern antibiotic discovery. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1862, 1300\u20131309 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"9947_CR46","doi-asserted-by":"publisher","unstructured":"Gold, B., Nathan, C. Targeting phenotypically tolerant Mycobacterium tuberculosis. Microbiol. Spectrum 5, https:\/\/doi.org\/10.1128\/microbiolspec.tbtb2-0031-2016 (2017).","DOI":"10.1128\/microbiolspec.tbtb2-0031-2016"},{"key":"9947_CR47","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","volume":"43","author":"JC Betts","year":"2002","unstructured":"Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A. & Duncan, K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43, 717\u2013731 (2002).","journal-title":"Mol. Microbiol."},{"key":"9947_CR48","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","volume":"36","author":"M Gengenbacher","year":"2012","unstructured":"Gengenbacher, M. & Kaufmann, S. H. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol. Rev. 36, 514\u2013532 (2012).","journal-title":"FEMS Microbiol. Rev."},{"key":"9947_CR49","doi-asserted-by":"publisher","first-page":"e2302858120","DOI":"10.1073\/pnas.2302858120","volume":"120","author":"Y Gong","year":"2023","unstructured":"Gong, Y. et al. Structure of the priming arabinosyltransferase AftA required for AG biosynthesis of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 120, e2302858120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9947_CR50","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.2174\/1381612823666170214115048","volume":"23","author":"JN Sangshetti","year":"2017","unstructured":"Sangshetti, J. N., Joshi, S. S., Patil, R. H., Moloney, M. G. & Shinde, D. B. Mur ligase inhibitors as anti-bacterials: a comprehensive review. Curr. Pharm. Des. 23, 3164\u20133196 (2017).","journal-title":"Curr. Pharm. Des."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09947-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09947-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09947-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:02:11Z","timestamp":1779753731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09947-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9947"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09947-7","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"709"}}